Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

MCP-1/CCL2 in a Bulgarian Cohort of Children with Bronchial Asthma and Cystic Fibrosis

Tsvetelina Velikova
* ORCID logo ,
Ekaterina Krasimirova
,
Snezhina Lazova
ORCID logo ,
Penka Perenovska
,
Anna Valerieva
,
Dimitrinka Miteva
,
Vasil Dimitrov
ORCID logo ,
Maria Staevska
,
Dobroslav Kyurkchiev
ORCID logo ,
Guergana Petrova
ORCID logo
Version 1 : Received: 20 April 2018 / Approved: 23 April 2018 / Online: 23 April 2018 (09:00:00 CEST)

A peer-reviewed article of this Preprint also exists.

V. Velikova, T.; Krasimirova, E.; M. Lazova, S.; I. Perenovska, P.; D. Valerieva, A.; S. Miteva, D.; D. Dimitrov, V.; T. Staevska, M.; S. Kyurkchiev, D.; Petrova, G. MCP-1/CCL2 in a Bulgarian Cohort of Children with Bronchial Asthma and Cystic Fibrosis. Archives of Immunology and Allergy 2018, 1, 1–5, doi:10.22259/2639-1848.0101001. V. Velikova, T.; Krasimirova, E.; M. Lazova, S.; I. Perenovska, P.; D. Valerieva, A.; S. Miteva, D.; D. Dimitrov, V.; T. Staevska, M.; S. Kyurkchiev, D.; Petrova, G. MCP-1/CCL2 in a Bulgarian Cohort of Children with Bronchial Asthma and Cystic Fibrosis. Archives of Immunology and Allergy 2018, 1, 1–5, doi:10.22259/2639-1848.0101001.

Abstract

C-C motif chemokine ligand 2 (CCL2), also called monocyte chemoattractant protein-1 (MCP-1) is a key β-chemokine involved in the migration of monocytes and macrophages, playing a significant role in the inflammatory responses in the airways. We aimed to assess the serum levels of MCP-1/CCL2 in a pilot cross-sectional study of Bulgarian children with bronchial asthma (BA) and cystic fibrosis (CF). Forty-two children were recruited to the study as follows: twenty with BA, twelve with CF and ten healthy children. Serum MCP-1/CCL2 levels were measured using ELISA. We found higher serum level of MCP-1/CCL2 in children with BA (191.09±64.96 pg/ml) and CF (258.51±76.45 pg/ml) compared to healthy children (70.30±64.30 pg/ml, p=0.022, and p=0.068, respectively). Younger patients with BA had higher levels of MCP-1/CCL2, as well as children with CF, with levels decreasing gradually with age. We observed also higher levels of MCP-1/CCL2 in children with moderate to severe BA compared to mild BA. We documented the significantly higher level of MCP-1/CCL2 in children with these chronic pulmonary diseases than in healthy controls, which suggesting that investigation of serum MCP-1/CCL2 levels could turn out to be beneficial for the severity of the disease.

Keywords

monocyte chemoattractant protein-1; MCP-1; C-C motif chemokine ligand 2; CCL2; childhood asthma; bronchial asthma; severe asthma; cystic fibrosis; chronic obstructive pulmonary disease

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.